Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
All Genders
ID06624462

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Led by Bjorn H. Ebdrup · Updated on 2026-01-08

84

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

B

Bjorn H. Ebdrup

Lead Sponsor

G

Glostrup University Hospital, Copenhagen

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the effectiveness of a pragmatic metabolic care clinic designed for patients with severe mental illness (SMI), including schizophrenia spectrum disorders and bipolar disorder. Patients with SMI face high mortality rates linked to cardiovascular disease, often worsened by obesity and metabolic issues caused by antipsychotic medications. The study seeks to improve cardiometabolic care by comparing specialized metabolic clinic treatment against standard care and also includes patient interviews to understand satisfaction and motivation. Participants will be randomly assigned to one of two groups: one receiving 12 months of treatment in the metabolic care clinic, which includes medical consultations, lifestyle interventions, medication evaluations, and coordinated care with specialists; the other group will continue standard care through their psychiatric outpatient clinic or general practitioner. Measurements and monitoring occur at enrollment, 6 months, and 12 months for the clinic group, and at enrollment and 12 months for the standard care group. Throughout the study, patients will undergo regular assessments including weight, waist circumference, blood pressure, cholesterol, glucose, and other cardiovascular risk factors. The primary outcome measures the proportion of patients achieving at least 5% weight loss after 12 months. Secondary outcomes assess broader metabolic and health indicators, quality of life, and cognitive function. Interviews will also explore patient experiences and factors influencing health behavior changes during the trial.

CONDITIONS

Brief Title

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Who Can Participate

Age: 18Years - 45Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with schizophrenia spectrum disorders (ICD-10: DF2x) or bipolar disorder (ICD-10: DF30.x or DF31.x)
  • Currently treated with antipsychotic medication
  • Age between 18 and 45 years
  • Legally competent and able to provide informed consent
  • Body mass index (BMI) of 30 kg/m2 or higher
  • Or BMI of 27 kg/m2 or higher with at least one of the following: hypertension, dyslipidaemia, sleep apnoea, prediabetes, or diabetes
  • Or history of rapid weight gain of 5% body weight or 5 cm waist circumference increase since starting antipsychotic therapy
Not Eligible

You will not qualify if you...

  • Presence of other medical diseases that make participation unsuitable
  • Unstable psychiatric condition as judged by the research team
  • Severe current misuse of drugs or alcohol
  • Acute risk of suicide

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 12 months

Participants receive treatment in a specialized metabolic clinic with consultations, lifestyle interventions, pharmacotherapy, and management of cardiovascular risk factors, or continue with standard care involving their general practitioner and/or outpatient clinics.

3 visits for treatment group (at enrollment, 6 months, and 12 months) and 2 visits for standard care group (at enrollment and 12 months)

Follow-up

Duration - Short period after 12 months

Qualitative interviews are conducted post-intervention to explore patient experience and contextual factors related to acceptability, satisfaction, and motivation for health behaviour change.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Centre for Neuropsychiatric Schizophrenia Research, CNSR, Mental Health Centre Glostrup

Glostrup Municipality, Capital Region, Denmark, 2600

Actively Recruiting

Loading map...

Research Team

B

Bjorn H. Ebdrup, MD, Consultant,PhD, Professor,

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Phase 3, Randomized, Double-blind, Placebo-Controlled Stud...

Bipolar Disorder

Actively Recruiting

28 locations

A Phase 2 Study to Assess Brenipatide Added to Standard Care...

Bipolar Disorder

Actively Recruiting

87 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here